685 related articles for article (PubMed ID: 7523453)
1. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
Hotamisligil GS; Budavari A; Murray D; Spiegelman BM
J Clin Invest; 1994 Oct; 94(4):1543-9. PubMed ID: 7523453
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase.
Cheung AT; Wang J; Ree D; Kolls JK; Bryer-Ash M
Diabetes; 2000 May; 49(5):810-9. PubMed ID: 10905491
[TBL] [Abstract][Full Text] [Related]
3. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha.
Cheung AT; Ree D; Kolls JK; Fuselier J; Coy DH; Bryer-Ash M
Endocrinology; 1998 Dec; 139(12):4928-35. PubMed ID: 9832430
[TBL] [Abstract][Full Text] [Related]
4. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
5. Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats.
Slieker LJ; Roberts EF; Shaw WN; Johnson WT
Diabetes; 1990 May; 39(5):619-25. PubMed ID: 2332119
[TBL] [Abstract][Full Text] [Related]
6. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance.
Hotamisligil GS; Peraldi P; Budavari A; Ellis R; White MF; Spiegelman BM
Science; 1996 Feb; 271(5249):665-8. PubMed ID: 8571133
[TBL] [Abstract][Full Text] [Related]
7. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.
Jiang ZY; Lin YW; Clemont A; Feener EP; Hein KD; Igarashi M; Yamauchi T; White MF; King GL
J Clin Invest; 1999 Aug; 104(4):447-57. PubMed ID: 10449437
[TBL] [Abstract][Full Text] [Related]
8. Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance.
Saad MJ; Araki E; Miralpeix M; Rothenberg PL; White MF; Kahn CR
J Clin Invest; 1992 Nov; 90(5):1839-49. PubMed ID: 1331176
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase.
Peraldi P; Hotamisligil GS; Buurman WA; White MF; Spiegelman BM
J Biol Chem; 1996 May; 271(22):13018-22. PubMed ID: 8662983
[TBL] [Abstract][Full Text] [Related]
10. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects.
Thies RS; Molina JM; Ciaraldi TP; Freidenberg GR; Olefsky JM
Diabetes; 1990 Feb; 39(2):250-9. PubMed ID: 2227134
[TBL] [Abstract][Full Text] [Related]
11. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats.
Saad MJ; Folli F; Kahn JA; Kahn CR
J Clin Invest; 1993 Oct; 92(4):2065-72. PubMed ID: 7691892
[TBL] [Abstract][Full Text] [Related]
12. Liver insulin receptor tyrosine kinase activity in a rat model of type II diabetes mellitus and obesity.
Adamo M; Shemer J; Aridor M; Dixon J; Carswell N; Bhathena SJ; Michaelis OE; LeRoith D
J Nutr; 1989 Mar; 119(3):484-9. PubMed ID: 2537893
[TBL] [Abstract][Full Text] [Related]
13. Reduction of adiposity with prolonged growth hormone treatment in old obese rats: effects on glucose handling and early insulin signaling.
Johansen T; Laurino C; Barreca A; Malmlöf K
Growth Horm IGF Res; 2005 Feb; 15(1):55-63. PubMed ID: 15701573
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of defective insulin-receptor kinase activity in NIDDM. Evidence for two receptor populations.
Brillon DJ; Freidenberg GR; Henry RR; Olefsky JM
Diabetes; 1989 Mar; 38(3):397-403. PubMed ID: 2465197
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of tumor necrosis factor-alpha on protein kinase C isoforms alpha and delta mediate inhibition of insulin receptor signaling.
Rosenzweig T; Braiman L; Bak A; Alt A; Kuroki T; Sampson SR
Diabetes; 2002 Jun; 51(6):1921-30. PubMed ID: 12031982
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha: a key component of the obesity-diabetes link.
Hotamisligil GS; Spiegelman BM
Diabetes; 1994 Nov; 43(11):1271-8. PubMed ID: 7926300
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1.
Kanety H; Feinstein R; Papa MZ; Hemi R; Karasik A
J Biol Chem; 1995 Oct; 270(40):23780-4. PubMed ID: 7559552
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.
Giorgino F; Almahfouz A; Goodyear LJ; Smith RJ
J Clin Invest; 1993 May; 91(5):2020-30. PubMed ID: 7683695
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats.
Hayakawa T; Shiraki T; Morimoto T; Shii K; Ikeda H
Biochem Biophys Res Commun; 1996 Jun; 223(2):439-44. PubMed ID: 8670300
[TBL] [Abstract][Full Text] [Related]
20. Phosphotyrosine-containing proteins in the CNS of obese Zucker rats are decreased in the absence of changes in the insulin receptor.
Livingston JN; Unger JW; Moxley RT; Moss A
Neuroendocrinology; 1993 Mar; 57(3):481-8. PubMed ID: 7686643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
